<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
MRNS
Marinus Pharmaceuticals
$
()


  • Marinus Pharmaceuticals just downgraded at Baird, here's why

    Today - 04:56am
  • What You Missed On Wall Street On Monday

    4/15/2024 - 16:23pm
  • Marinus Pharmaceuticals downgraded to Sector Perform at RBC Capital

    4/15/2024 - 12:55pm
  • What You Missed On Wall Street This Morning

    4/15/2024 - 12:52pm
  • Marinus expects Phase 3 Trust TSC trial of ZTALMY in mid-May 2024

    4/15/2024 - 07:14am
  • Marinus Pharmaceuticals sees Q1 revenue $7.4M-$7.6M, consensus $9.08M

    4/15/2024 - 07:12am
  • Marinus trial did not meet stopping criteria at the interim analysis

    4/15/2024 - 07:08am
  • Marinus Comments on patent challenge by Ovid Therapeutics

    3/27/2024 - 08:50am
  • Marinus Pharmaceuticals management to meet with Jefferies

    3/11/2024 - 17:55pm
  • Marinus Pharmaceuticals management to meet with Jefferies

    3/11/2024 - 10:28am
  • Marinus Pharmaceuticals' ganaxolone approved by MHRA

    3/7/2024 - 12:45pm
  • Marinus Pharmaceuticals sees FY24 U.S. ZTALMY revenue $32M-$34M

    3/5/2024 - 16:06pm
  • Marinus Pharmaceuticals reports Q4 EPS (74c), consensus (62c)

    3/5/2024 - 16:05pm
  • Marinus Pharmaceuticals sees FY23 U.S. ZTALMY revenue $19.5M-$19.7M

    1/4/2024 - 07:15am
  • Marinus Pharmaceuticals price target lowered to $13 from $15 at Ladenburg

    11/8/2023 - 06:41am
dynamic_feed Breaking News